These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 35488516)

  • 1. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
    Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y
    J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance between MR amide proton transfer (APT) and diffusion kurtosis imaging (DKI) in glioma grading and IDH mutation status prediction at 3 T.
    Xu Z; Ke C; Liu J; Xu S; Han L; Yang Y; Qian L; Liu X; Zheng H; Lv X; Wu Y
    Eur J Radiol; 2021 Jan; 134():109466. PubMed ID: 33307459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Isocitrate Dehydrogenase Genotype in Brain Gliomas with MRI: Single-Shell versus Multishell Diffusion Models.
    Figini M; Riva M; Graham M; Castelli GM; Fernandes B; Grimaldi M; Baselli G; Pessina F; Bello L; Zhang H; Bizzi A
    Radiology; 2018 Dec; 289(3):788-796. PubMed ID: 30277427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status.
    Zhao J; Wang YL; Li XB; Hu MS; Li ZH; Song YK; Wang JY; Tian YS; Liu DW; Yan X; Jiang L; Yang ZY; Chu JP
    J Neurooncol; 2019 Jan; 141(1):195-203. PubMed ID: 30414095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-Tumor Histogram Analysis of Multiple Diffusion Metrics for Glioma Genotyping.
    Gao A; Zhang H; Yan X; Wang S; Chen Q; Gao E; Qi J; Bai J; Zhang Y; Cheng J
    Radiology; 2022 Mar; 302(3):652-661. PubMed ID: 34874198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
    Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J
    Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Multiregional Mean Apparent Propagator (MAP) Features in Evaluating Gliomas-A Comparative Study With Diffusion Kurtosis Imaging (DKI).
    Zeng S; Ma H; Xie D; Huang Y; Yang J; Lin F; Ma Z; Wang M; Yang Z; Zhao J; Chu J
    J Magn Reson Imaging; 2023 Dec; ():. PubMed ID: 38131220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
    Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
    Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amide proton transfer-weighted imaging and derived radiomics in the classification of adult-type diffuse gliomas.
    Wu M; Jiang T; Guo M; Duan Y; Zhuo Z; Weng J; Xie C; Sun J; Li J; Cheng D; Liu X; Du J; Zhang X; Zhang Y; Liu Y
    Eur Radiol; 2024 May; 34(5):2986-2996. PubMed ID: 37855851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.
    Paech D; Windschuh J; Oberhollenzer J; Dreher C; Sahm F; Meissner JE; Goerke S; Schuenke P; Zaiss M; Regnery S; Bickelhaupt S; Bäumer P; Bendszus M; Wick W; Unterberg A; Bachert P; Ladd ME; Schlemmer HP; Radbruch A
    Neuro Oncol; 2018 Nov; 20(12):1661-1671. PubMed ID: 29733378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation between high-grade gliomas and solitary brain metastases: a comparison of five diffusion-weighted MRI models.
    Mao J; Zeng W; Zhang Q; Yang Z; Yan X; Zhang H; Wang M; Yang G; Zhou M; Shen J
    BMC Med Imaging; 2020 Nov; 20(1):124. PubMed ID: 33228564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D Amide Proton Transfer-Weighted Imaging for Grading Glioma and Correlating IDH Mutation Status: Added Value to 3D Pseudocontinuous Arterial Spin Labelling Perfusion.
    Hou H; Chen W; Diao Y; Wang Y; Zhang L; Wang L; Xu M; Yu J; Song T; Liu Y; Yuan Z
    Mol Imaging Biol; 2023 Apr; 25(2):343-352. PubMed ID: 35962302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mean apparent propagator-MRI in evaluation of glioma grade, cellular proliferation, and IDH-1 gene mutation status.
    Sun Y; Su C; Deng K; Hu X; Xue Y; Jiang R
    Eur Radiol; 2022 Jun; 32(6):3744-3754. PubMed ID: 35076759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of neurite orientation dispersion and density imaging in grading gliomas and detecting
    Zhao J; Li JB; Wang JY; Wang YL; Liu DW; Li XB; Song YK; Tian YS; Yan X; Li ZH; He SF; Huang XL; Jiang L; Yang ZY; Chu JP
    Neuroimage Clin; 2018; 19():174-181. PubMed ID: 30023167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient.
    Maynard J; Okuchi S; Wastling S; Busaidi AA; Almossawi O; Mbatha W; Brandner S; Jaunmuktane Z; Koc AM; Mancini L; Jäger R; Thust S
    Radiology; 2020 Jul; 296(1):111-121. PubMed ID: 32315266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
    Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying MAP-MRI to Identify the WHO Grade and Main Genetic Features of Adult-type Diffuse Gliomas: A Comparison of Three Diffusion-weighted MRI Models.
    Wang P; He J; Ma X; Weng L; Wu Q; Zhao P; Ban C; Hao X; Hao Z; Yuan P; Hao F; Wang S; Zhang H; Xie S; Gao Y
    Acad Radiol; 2023 Jul; 30(7):1238-1246. PubMed ID: 36347664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of MR diffusion kurtosis and neurite orientation dispersion and density imaging in evaluating gliomas.
    Genç B; Aslan K; Özçağlayan A; İncesu L
    J Neuroimaging; 2023; 33(4):644-651. PubMed ID: 37170070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-component multi-b-value diffusion-weighted imaging might be a useful biomarker for detecting microstructural features in gliomas with differences in malignancy and IDH-1 mutation status.
    Cao M; Wang X; Liu F; Xue K; Dai Y; Zhou Y
    Eur Radiol; 2023 Apr; 33(4):2871-2880. PubMed ID: 36346441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.